The recent work of Melo and colleagues [30] also showed that isolation of EVs was necessary to provide a more reliable (Glypican-1-based) diagnostic test for patients with pancreatic cancer, irrespective of the unclear intracellular origin of their marker [31]. The gene discussed is GPC1; the disease is pancreatic neoplasm.